Ginger : Medicinal uses

Last Verified: 2026-06-05 | Author: Kateule Sydney | Published by E-cyclopedia Resources

Zingiber officinale ━━━━━━━━━━━━━━━━━━━━━━ A medicinal powerhouse with over 2,500 years of therapeutic use across global healing traditions

Fresh ginger rhizome (Zingiber officinale) — a medicinal powerhouse with over 2,500 years of therapeutic use across global healing traditions

Summary: Ginger (Zingiber officinale Roscoe) is a perennial herb of the Zingiberaceae family, widely used as both a culinary spice and medicinal plant. Its therapeutic properties derive primarily from bioactive phenolic compounds including gingerols, shogaols, and paradols. Ginger demonstrates well-established efficacy for nausea and vomiting prevention (particularly motion sickness and pregnancy-related nausea), with emerging evidence supporting anti-inflammatory, antioxidant, antimicrobial, and neuroprotective effects through modulation of multiple signaling pathways including NF-κB, Nrf2, and MAPK.

```

Table of Contents

• Chapter 1 — Bioactive Compounds: Gingerols, Shogaols, and Paradols
• Chapter 2 — Anti-inflammatory and Antioxidant Effects: Meta-Analysis Evidence
• Chapter 3 — Nausea, Vomiting, and Digestive Health
• Chapter 4 — Emerging Applications: Respiratory Infections and Bone Health
• Chapter 5 — Safety Profile and Drug Interactions
• FAQ
• References

Chapter 1 — Bioactive Compounds: Gingerols, Shogaols, and Paradols

1.1 Chemical Composition and Transformation

Ginger rhizome contains over 400 phytochemicals, with the most pharmacologically significant being phenolic compounds: gingerols, shogaols, and paradols. Fresh ginger primarily contains gingerols — predominantly 6-gingerol (the most abundant), 8-gingerol, and 10-gingerol — which constitute the "general term for a series of compounds of 3-methoxy-4-hydroxyphenyl functional group". These compounds impart the characteristic pungent taste and biological activities including antioxidant, anti-inflammatory, anticancer, cardiovascular protection, metabolism regulation, antibacterial, antiemetic, and neuroprotective effects [citation:2]. During thermal processing (drying, cooking) or prolonged storage, gingerols undergo dehydration through acid catalysis, converting to shogaols by eliminating a hydroxide radical at C-5 and forming a double bond. This transformation explains why dried ginger contains higher shogaol concentrations — 6-shogaol content increases from 0.09 mg/g in fresh ginger to 0.384 mg/g after microwave drying. Shogaols themselves can further metabolize to paradols via reduction of their double bond. In terms of chemical structure differences: gingerols contain a β-hydroxyl ketone structure, while shogaols contain an α-β unsaturated ketone structure, which contributes to their different biological activity mechanisms and potency [citation:2].

Key bioactive compounds and their properties:

• 6-Gingerol: Most abundant in fresh ginger; pale yellow oil with pungent, bitter taste; antioxidant, anti-inflammatory, antiemetic; converts to 6-shogaol upon heating.
• 6-Shogaol: Formed from 6-gingerol dehydration; reactive Michael acceptor moiety; enhanced anti-inflammatory activity; more stable than gingerol; primary bioactive in dried ginger preparations.
• 6-Paradol: Downstream metabolite from 6-shogaol via microbial biotransformation; anti-inflammatory, antiviral, anticancer, and neuroprotective properties.
• Zingerone: Formed from gingerols after heat application; contributes to warming taste; antioxidant and anti-inflammatory effects.
• Gingerenone A (GIA): Demonstrated novel TLR signaling pathway modulation; anti-obesity, anti-tumor, anti-hyperglycemia, and anti-inflammatory effects.

Research significance: A 2025 comprehensive review in ScienceDirect systematically summarized differences in biological mechanisms between gingerols and shogaols at signaling pathway and metabolite levels. The study noted that "6-shogaol is characterized by a Michael acceptor moiety being reactive with nucleophiles," explaining its enhanced bioactivity. The review emphasized that understanding these mechanistic differences provides theoretical basis for further clinical research and enables optimization of ginger processing methods to maximize therapeutic efficacy [citation:2].

References:
Biological mechanisms, pharmacological and pathological activities, and quality optimization of gingerols and shogaols - ScienceDirect
Benefits of Ginger and Its Constituent 6-Shogaol in Inhibiting Inflammatory Processes - NIH/PMC

Chapter 2 — Anti-inflammatory and Antioxidant Effects: Meta-Analysis Evidence

⬅ Back to Table of Contents

2.1 Systematic Review and Meta-Analysis of RCTs

A comprehensive GRADE-assessed systematic review and dose-response meta-analysis published in Inflammopharmacology (2025) evaluated 29 randomized controlled trials examining ginger supplementation effects on inflammatory and antioxidant biomarkers. The meta-analysis searched PubMed, Scopus, Web of Science Core Collection, and Google Scholar databases. Results demonstrated significant improvements across all measured biomarkers. Ginger supplementation reduced C-reactive protein (CRP) by 0.86 mg/L, tumor necrosis factor α (TNF-α) by 1.90 pg/mL, and interleukin-6 (IL-6) by 1.15 pg/mL. Antioxidant capacity showed total antioxidant capacity (TAC) increased by 0.22 mmol/L, while malondialdehyde (MDA, a lipid peroxidation marker) decreased by 0.76 mcmol/L, and superoxide dismutase (SOD) increased by 48.12 u/L. The effect on IL-6 demonstrated non-linear associations with both dosage and duration of intervention. The authors concluded that ginger supplementation "may improve inflammatory and antioxidant biomarkers, particularly in individuals with underlying health conditions," while cautioning that high heterogeneity among studies requires cautious interpretation [citation:1].

Mechanisms of anti-inflammatory action:

• NF-κB pathway inhibition: Ginger compounds suppress nuclear factor kappa B activation, reducing pro-inflammatory cytokine production (TNF-α, IL-1β, IL-6).
• COX-2 and iNOS suppression: 6-Shogaol reduces cyclooxygenase-2 and inducible nitric oxide synthase expression, decreasing prostaglandin E2 and NO levels.
• Nrf2 pathway activation: Upregulates antioxidant response elements, increasing SOD, CAT, GPx, and HO-1 expression.
• MAPK signaling modulation: Affects p38, ERK, and JNK pathways involved in inflammatory responses.
• TLR signaling regulation: Gingerenone A suppresses both MyD88- and TRIF-dependent Toll-like receptor pathways, representing a novel anti-inflammatory mechanism [citation:3].

Preclinical evidence: Studies dating to 1989 demonstrated ginger extract's anti-inflammatory effects comparable to acetylsalicylic acid, reducing carrageenan-induced paw edema by 22-38% in rats. A case series of seven rheumatoid arthritis patients consuming 5g fresh or 0.5-1g dried ginger over three months reported pain relief, improved joint agility, and reduced stiffness [citation:9].

References:
Antioxidant and anti-inflammatory effects of ginger supplementation - Springer/Inflammopharmacology
6-Shogaol anti-inflammatory mechanisms - NIH/PMC
Gingerenone A modulates TLR signaling pathways - ScienceDirect/European Journal of Pharmacology

Chapter 3 — Nausea, Vomiting, and Digestive Health

3.1 Well-Established Uses and Mechanisms

The Committee on Herbal Medicinal Products (HMPC) of the European Medicines Agency (EMA) has classified dried ginger rhizome as having "well-established use" for the prevention of nausea and vomiting in motion sickness. Additionally, ginger is approved as a "traditional herbal medicinal product for the treatment of mild, spasmodic gastrointestinal complaints including bloating and flatulence" [citation:9]. According to the Johns Hopkins Health Library, ginger reduces nausea through a direct effect on the stomach rather than on the central nervous system. Research shows ginger is safe and effective for pregnancy-related nausea (morning sickness), with these effects attributed to gingerols. While conflicting reports exist regarding whether ginger increases stomach emptying speed, it does increase movement of the rest of the gastrointestinal system. Ginger has also been used to treat nausea due to mild gastrointestinal infections, vertigo, post-surgical nausea, and chemotherapy-induced vomiting, though studies show mixed results for these applications [citation:4].

EMA-approved and traditional digestive indications:

• Motion sickness prevention: Well-established use classification based on sufficient evidence from clinical studies.
• Pregnancy-related nausea (morning sickness): Safe and effective; women who are pregnant should consult healthcare providers before use.
• Spasmodic gastrointestinal complaints: Traditional use for bloating, flatulence, and mild digestive discomfort.
• Post-operative and chemotherapy-induced nausea: Mixed evidence; requires further research for definitive recommendations.

References:
Ginger - Johns Hopkins Health Library
HMPC classification of ginger - NIH/PMC

Chapter 4 — Emerging Applications: Respiratory Infections and Bone Health

⬅ Back to Table of Contents

4.1 COVID-19 and Osteoporosis Research

Recent research has identified novel therapeutic applications for ginger in respiratory infections and metabolic bone disease. A systematic review of randomized controlled trials for acute respiratory infections (ARIs) published in 2025 identified one eligible RCT involving 227 adult participants with asymptomatic COVID-19. Ginger powder (1.5 g twice daily in warm water) reduced quarantine duration by 2.4 days (95% CI 1.6-3.2) compared to usual care alone, with greater effects observed in participants aged 60 years or older, men, and those with pre-existing medical conditions. However, the study was at high risk of bias due to concerns about randomization and lack of blinding, and no adverse event data were reported. The review concluded that "more high-quality randomized controlled clinical trials are needed to assess the efficacy of ginger for the treatment of ARIs" [citation:7].

Computational studies have investigated ginger-derived phenolics against SARS-CoV-2 main protease (Mpro). A 2025 study using molecular docking and 500-nanosecond molecular dynamics simulations found that shogaol exhibited the strongest binding affinity (−9.95 kcal/mol) among tested compounds, forming stable hydrogen and hydrophobic interactions with key active site residues. Pharmacokinetic profiling revealed favorable ADMET characteristics and low toxicity profiles. The study concluded that "shogaol may serve as promising candidates for the development of novel therapeutics targeting COVID-19 main protease" [citation:8].

In the field of bone health, a 2025 review published in Frontiers in Pharmacology summarized clinical and basic research on ginger's anti-osteoporotic effects. Ginger bioactive metabolites act through multiple signaling pathways including NF-κB, Wnt/β-catenin, MAPK, GSK3β/Nrf2, and RANK/RANKL/OPG. A randomized triple-blind placebo-controlled clinical trial on 120 postmenopausal women with osteoporosis found that ginger supplementation (60.88 mg gingerol daily for 4 months) increased bone mineral density in the femoral neck and lumbar spine, decreased alkaline phosphatase levels, reduced serum hs-CRP and IL-6, enhanced total antioxidant capacity and SOD, while decreasing MDA levels. The study concluded that "ginger and curcumin can enhance BMD, improve bone turnover markers, reduce inflammation, and enhance antioxidant activity in postmenopausal women with OP" [citation:6].

Summary of emerging applications:

• Acute respiratory infections/COVID-19: Ginger powder 1.5g twice daily reduced quarantine duration by 2.4 days (single RCT, high bias risk; requires confirmation).
• Osteoporosis: 4-month ginger supplementation (60.88 mg gingerol/day) increased BMD and improved bone turnover markers in postmenopausal women.
• SARS-CoV-2 Mpro inhibition: In silico studies show shogaol binding affinity −9.95 kcal/mol, favorable ADMET profile.

References:
Safety and effectiveness of ginger for acute respiratory infections - ScienceDirect
Ginger-derived phenolics for SARS-CoV-2 main protease inhibition - NIH/PMC
Potential mechanism of ginger in alleviating osteoporosis - NIH/PMC

Chapter 5 — Safety Profile and Drug Interactions

5.1 Adverse Effects and Bleeding Risk

Ginger is generally recognized as safe when consumed in normal food and supplement doses. However, adverse effects may include heartburn and bloating at higher doses. The primary safety concern involves potential pharmacodynamic interactions with anticoagulant and antiplatelet medications. A 2025 case report described a 69-year-old male with a history of liver transplantation, renal failure, hypertension, and obliterative arteriopathy of the lower limbs (OALL) who was undergoing clopidogrel treatment (75 mg/day). After he began consuming candied ginger added to beverages, he experienced bleeding complications. The report noted that ginger's pungent compounds (primarily gingerols) inhibit platelet function by inhibiting platelet activation and decreasing thromboxane synthesis. However, the authors stated that "the clinical data are contradictory, particularly with regard to the risk of bleeding when used concomitantly with anticoagulant and/or antiplatelet drugs" and that "further studies are required to confirm and assess this risk" [citation:5][citation:10].

Safety considerations and contraindications:

• Anticoagulant/antiplatelet interaction: Gingerols inhibit platelet aggregation and decrease thromboxane synthesis. Patients taking warfarin, clopidogrel, aspirin, or other blood thinners should consult healthcare providers before ginger supplementation.
• Pregnancy and breastfeeding: Pregnant women should consult healthcare providers before taking ginger supplements, though food amounts are considered safe. Johns Hopkins notes ginger is safe and effective for morning sickness but recommends medical consultation [citation:4].
• Surgery: Due to potential antiplatelet effects, some sources recommend discontinuing ginger supplements at least 2 weeks before elective surgery, though evidence for significant bleeding risk remains mixed.
• Gallstones: Theoretical concern that ginger may increase bile production, though clinical significance uncertain.

Quality and contamination concerns: Like all herbal products, ginger supplements may vary in quality and potency. Consumers should purchase from reputable manufacturers that perform third-party testing for contaminants including heavy metals, pesticides, and microbial pathogens.

References:
Pharmacodynamic interaction between ginger and antiplatelet drugs - ScienceDirect
Herbal supplement antiplatelet effects - NIH/PMC
Ginger safety profile - Johns Hopkins Health Library

5.2 Free Download: Ginger Medicinal Uses Quick Reference Card

A printable quick reference summarizing ginger's medicinal applications, bioactive compounds, dosing considerations, and safety warnings — designed for healthcare practitioners and patients.

=== GINGER MEDICINAL USES QUICK REFERENCE ===
[ACTIVE COMPOUNDS]
Fresh ginger: 6-gingerol (primary), 8-gingerol, 10-gingerol
Dried/processed ginger: 6-shogaol (enhanced bioactivity), paradols
Conversion: gingerols → (heat/dehydration) → shogaols → (metabolism) → paradols

[WELL-ESTABLISHED USES (EMA Classification)]
• Motion sickness prevention (well-established use)
• Mild spasmodic GI complaints, bloating, flatulence (traditional use)
• Pregnancy-related nausea/morning sickness (safe and effective)

[EVIDENCE-BASED BIOMARKER EFFECTS (2025 Meta-Analysis, 29 RCTs)]
↓ CRP: −0.86 mg/L ↑ TAC: +0.22 mmol/L
↓ TNF-α: −1.90 pg/mL ↓ MDA: −0.76 mcmol/L
↓ IL-6: −1.15 pg/mL ↑ SOD: +48.12 u/L

[EMERGING APPLICATIONS (Requires Further Research)]
• Osteoporosis: 60.88 mg gingerol/day ×4 months ↑ BMD (1 RCT)
• COVID-19: 1.5g powder twice daily reduced quarantine by 2.4 days (1 RCT, high bias)
• SARS-CoV-2 Mpro inhibition: Shogaol binding −9.95 kcal/mol (in silico)

[TYPICAL DOSING]
Motion sickness/pregnancy nausea: 0.5-1.5g dried ginger powder daily
Inflammation: 1-2g fresh or dried ginger daily
Osteoporosis supplement: 60.88 mg gingerol equivalent/day (clinical trial)

[SAFETY WARNINGS]
⚠ Anticoagulants/antiplatelets (warfarin, clopidogrel, aspirin): Possible additive bleeding risk
⚠ Surgery: Consider discontinuing 2 weeks pre-procedure
⚠ Pregnancy: Consult provider before supplement use (food amounts safe)
⚠ Side effects: Heartburn, bloating (higher doses)

[MECHANISM SNAPSHOT]
Anti-inflammatory: ↓NF-κB, ↓COX-2, ↓iNOS, ↓TLR signaling (MyD88/TRIF)
Antioxidant: ↑Nrf2, ↑SOD, ↑GPx, ↑HO-1
Antiplatelet: ↓Thromboxane synthesis, ↓platelet activation
===============================================================
Source: E-cyclopedia Resources | Last Verified: 2026-06-05

⬇ Download .TXT Template

FAQ

Is fresh ginger or dried ginger more effective for medicinal use?

Fresh and dried ginger have different bioactive profiles. Fresh ginger contains higher concentrations of gingerols (primarily 6-gingerol), which are potent anti-inflammatory and antiemetic compounds. Dried or heat-processed ginger contains higher levels of shogaols, formed from gingerol dehydration. Shogaols (particularly 6-shogaol) demonstrate enhanced bioactivity in some studies due to their Michael acceptor moiety, which makes them more reactive with cellular targets. For nausea and motion sickness, both forms are effective. For anti-inflammatory effects, dried ginger may offer advantages due to shogaol's potency. The choice depends on the condition and available evidence for specific applications.

References:
Fresh vs. dried ginger compound comparison - ScienceDirect

Can ginger interact with my blood pressure or diabetes medications?

Ginger may have blood pressure-lowering and blood glucose-lowering effects, though evidence quality varies. Patients taking antihypertensive medications or insulin/oral hypoglycemic agents should monitor blood pressure and blood glucose when initiating ginger supplementation, as additive effects could theoretically cause hypotension or hypoglycemia. The primary documented drug interaction involves antiplatelet/anticoagulant medications (warfarin, clopidogrel, aspirin) due to ginger's inhibition of platelet aggregation and thromboxane synthesis. Always inform healthcare providers about ginger supplement use, particularly before surgery or when taking blood thinners.

References:
Ginger-antiplatelet drug interaction case report - ScienceDirect

What dose of ginger is effective for nausea?

For motion sickness and pregnancy-related nausea, typical effective doses range from 0.5-1.5 grams of dried ginger powder daily, often divided into multiple doses. For morning sickness, some studies have used 250 mg four times daily. Ginger tea can be prepared by steeping 1-2 grams of fresh sliced ginger in hot water for 10-15 minutes. The EMA has classified 0.5-1.5g dried ginger powder as a well-established use for motion sickness prevention. Higher doses (up to 2-4g daily) have been studied for inflammatory conditions but may increase risk of heartburn and gastrointestinal side effects.

References:
Ginger dosing for nausea - NIH/PMC

Does ginger help with osteoarthritis pain?

Clinical studies suggest ginger may reduce pain and improve function in knee osteoarthritis. A double-blind randomized controlled trial involving 120 participants found that ginger powder (1g daily) demonstrated anti-inflammatory effects comparable to some NSAIDs with fewer gastrointestinal side effects. The anti-inflammatory mechanisms involve COX-2 inhibition (similar to NSAIDs) and suppression of pro-inflammatory cytokines including TNF-α, IL-1β, and IL-6. However, patients should not substitute prescribed osteoarthritis medications with ginger without medical supervision. Ginger may serve as an adjunctive therapy, but evidence quality varies across studies.

References:
Ginger for knee osteoarthritis - NIH/PMC

Related Topics

• Turmeric and Curcumin Anti-inflammatory Effects
• Natural Anti-emetic Agents
• Herbal Medicine for Motion Sickness
• Nrf2 Pathway Activators in Natural Products
• Zingiberaceae Family Medicinal Plants

References

Antioxidant and anti-inflammatory effects of ginger supplementation: GRADE-assessed meta-analysis - Springer/Inflammopharmacology

Biological mechanisms, pharmacological and pathological activities of gingerols and shogaols - ScienceDirect

Gingerenone A modulation of Toll-like receptor signaling pathways - European Journal of Pharmacology

Ginger - Johns Hopkins Health Library

Pharmacodynamic interaction between ginger and antiplatelet drugs - ScienceDirect

Potential mechanism of ginger in alleviating osteoporosis - NIH/PMC

Safety and effectiveness of ginger for acute respiratory infections - ScienceDirect

Ginger-derived phenolics for SARS-CoV-2 main protease inhibition - NIH/PMC

Benefits of Ginger and 6-Shogaol in inhibiting inflammatory processes - NIH/PMC

Herbal supplement antiplatelet effects summary - NIH/PMC

```